source name	characteristics[organism]	characteristics[organism part]	characteristics[individual]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[developmental stage]	characteristics[disease]	characteristics[depletion]	comment[biological replicate]	characteristics[sampling time]	assay name	Technology type	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[label]	comment[technical replicate]	comment[cleavage agent details]	comment[cleavage agent details]	comment[MS2 mass analyzer]	comment[instrument]	comment[separation]	comment[modification parameter]	comment[modification parameter]	comment[modification parameter]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	value[organism part]
PXD002854-Sample-Plasma-1	Homo sapiens	Blood plasma	1	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20140903_QEp1_LC7_PhGe_SA_4_48_Top6_Top20_1	proteomic profiling by mass spectrometry	20140903_QEp1_LC7_PhGe_SA_4_48_Top6_Top20_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20140903_QEp1_LC7_PhGe_SA_4_48_Top6_Top20_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-1	Homo sapiens	Blood plasma	1	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20140903_QEp1_LC7_PhGe_SA_4_48_Top6_Top20_2	proteomic profiling by mass spectrometry	20140903_QEp1_LC7_PhGe_SA_4_48_Top6_Top20_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20140903_QEp1_LC7_PhGe_SA_4_48_Top6_Top20_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-1	Homo sapiens	Blood plasma	1	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20140903_QEp1_LC7_PhGe_SA_4_48_Top6_Top20_3	proteomic profiling by mass spectrometry	20140903_QEp1_LC7_PhGe_SA_4_48_Top6_Top20_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20140903_QEp1_LC7_PhGe_SA_4_48_Top6_Top20_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-1	Homo sapiens	Blood plasma	2	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20150202_QEp2_LC11_PhGe_SA_4_57_B1	proteomic profiling by mass spectrometry	20150202_QEp2_LC11_PhGe_SA_4_57_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20150202_QEp2_LC11_PhGe_SA_4_57_B1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-2	Homo sapiens	Blood plasma	2	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20150202_QEp2_LC11_PhGe_SA_4_57_B2	proteomic profiling by mass spectrometry	20150202_QEp2_LC11_PhGe_SA_4_57_B2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20150202_QEp2_LC11_PhGe_SA_4_57_B2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-2	Homo sapiens	Blood plasma	2	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20150202_QEp2_LC11_PhGe_SA_4_57_B3	proteomic profiling by mass spectrometry	20150202_QEp2_LC11_PhGe_SA_4_57_B3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20150202_QEp2_LC11_PhGe_SA_4_57_B3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-2	Homo sapiens	Blood plasma	2	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20150202_QEp2_LC11_PhGe_SA_4_57_B4	proteomic profiling by mass spectrometry	20150202_QEp2_LC11_PhGe_SA_4_57_B4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20150202_QEp2_LC11_PhGe_SA_4_57_B4.raw	1	AC=MS:1002038;NT=label free	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-2	Homo sapiens	Blood plasma	2	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20150202_QEp2_LC11_PhGe_SA_4_57_B5	proteomic profiling by mass spectrometry	20150202_QEp2_LC11_PhGe_SA_4_57_B5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20150202_QEp2_LC11_PhGe_SA_4_57_B5.raw	1	AC=MS:1002038;NT=label free	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-2	Homo sapiens	Blood plasma	2	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20150202_QEp2_LC11_PhGe_SA_4_57_B6	proteomic profiling by mass spectrometry	20150202_QEp2_LC11_PhGe_SA_4_57_B6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20150202_QEp2_LC11_PhGe_SA_4_57_B6.raw	1	AC=MS:1002038;NT=label free	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-2	Homo sapiens	Blood plasma	2	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20150202_QEp2_LC11_PhGe_SA_4_57_B7	proteomic profiling by mass spectrometry	20150202_QEp2_LC11_PhGe_SA_4_57_B7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20150202_QEp2_LC11_PhGe_SA_4_57_B7.raw	1	AC=MS:1002038;NT=label free	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-2	Homo sapiens	Blood plasma	2	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20150202_QEp2_LC11_PhGe_SA_4_57_B8	proteomic profiling by mass spectrometry	20150202_QEp2_LC11_PhGe_SA_4_57_B8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20150202_QEp2_LC11_PhGe_SA_4_57_B8.raw	1	AC=MS:1002038;NT=label free	8	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-2	Homo sapiens	Blood plasma	2	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20150202_QEp2_LC11_PhGe_SA_4_57_B9	proteomic profiling by mass spectrometry	20150202_QEp2_LC11_PhGe_SA_4_57_B9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20150202_QEp2_LC11_PhGe_SA_4_57_B9.raw	1	AC=MS:1002038;NT=label free	9	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-2	Homo sapiens	Blood plasma	2	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20150202_QEp2_LC11_PhGe_SA_4_57_B10	proteomic profiling by mass spectrometry	20150202_QEp2_LC11_PhGe_SA_4_57_B10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20150202_QEp2_LC11_PhGe_SA_4_57_B10.raw	1	AC=MS:1002038;NT=label free	10	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-3	Homo sapiens	Blood plasma	3	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_F1_1	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_F1_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_F1_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-3	Homo sapiens	Blood plasma	3	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_F1_2	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_F1_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_F1_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-3	Homo sapiens	Blood plasma	3	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_F1_3	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_F1_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_F1_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-4	Homo sapiens	Blood plasma	4	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_F5_1	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_F5_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_F5_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-4	Homo sapiens	Blood plasma	4	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_F5_2	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_F5_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_F5_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-4	Homo sapiens	Blood plasma	4	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_F5_3	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_F5_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_F5_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-5	Homo sapiens	Blood plasma	5	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_F8_1	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_F8_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_F8_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-5	Homo sapiens	Blood plasma	5	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_F8_2	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_F8_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_F8_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-5	Homo sapiens	Blood plasma	5	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_F8_3	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_F8_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_F8_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-6	Homo sapiens	Blood plasma	6	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_F13_1	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_F13_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_F13_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-6	Homo sapiens	Blood plasma	6	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_F13_2	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_F13_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_F13_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-6	Homo sapiens	Blood plasma	6	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_F13_3	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_F13_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_F13_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-7	Homo sapiens	Blood plasma	7	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_F14_1	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_F14_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_F14_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-7	Homo sapiens	Blood plasma	7	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_F14_2	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_F14_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_F14_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-7	Homo sapiens	Blood plasma	7	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_F14_3	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_F14_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_F14_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-8	Homo sapiens	Blood plasma	8	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_M2_1	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_M2_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_M2_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-8	Homo sapiens	Blood plasma	8	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_M2_2	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_M2_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_M2_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-8	Homo sapiens	Blood plasma	8	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_M2_3	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_M2_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_M2_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-9	Homo sapiens	Blood plasma	9	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_M10_1	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_M10_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_M10_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-9	Homo sapiens	Blood plasma	9	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_M10_2	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_M10_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_M10_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-9	Homo sapiens	Blood plasma	9	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_M10_3	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_M10_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_M10_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-10	Homo sapiens	Blood plasma	10	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_M11__1	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_M11__1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_M11__1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-10	Homo sapiens	Blood plasma	10	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_M11_2	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_M11_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_M11_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-10	Homo sapiens	Blood plasma	10	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_M11_3	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_M11_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_M11_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-11	Homo sapiens	Blood plasma	11	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_M18_1	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_M18_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_M18_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-11	Homo sapiens	Blood plasma	11	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_M18_2	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_M18_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_M18_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-11	Homo sapiens	Blood plasma	11	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_M18_3	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_M18_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_M18_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-12	Homo sapiens	Blood plasma	12	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_M20_1_160113135254	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_M20_1_160113135254.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_M20_1_160113135254.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-12	Homo sapiens	Blood plasma	12	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_M20_2	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_M20_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_M20_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-12	Homo sapiens	Blood plasma	12	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20160112_QEp1_LC7_PhGe_SA_M20_3	proteomic profiling by mass spectrometry	20160112_QEp1_LC7_PhGe_SA_M20_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20160112_QEp1_LC7_PhGe_SA_M20_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-13	Homo sapiens	Blood plasma	13	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PG_4_53_M1_1	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PG_4_53_M1_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PG_4_53_M1_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-13	Homo sapiens	Blood plasma	13	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PG_4_53_M1_2	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PG_4_53_M1_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PG_4_53_M1_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-13	Homo sapiens	Blood plasma	13	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M1_3	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M1_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M1_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-13	Homo sapiens	Blood plasma	13	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M1_4	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M1_4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M1_4.raw	1	AC=MS:1002038;NT=label free	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-14	Homo sapiens	Blood plasma	14	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M2_1	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M2_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M2_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-14	Homo sapiens	Blood plasma	14	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M2_2	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M2_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M2_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-14	Homo sapiens	Blood plasma	14	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M2_3	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M2_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M2_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-14	Homo sapiens	Blood plasma	14	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M2_4	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M2_4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M2_4.raw	1	AC=MS:1002038;NT=label free	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-15	Homo sapiens	Blood plasma	15	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M3_1	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M3_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M3_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-15	Homo sapiens	Blood plasma	15	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M3_2	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M3_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M3_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-15	Homo sapiens	Blood plasma	15	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M3_3	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M3_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M3_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-15	Homo sapiens	Blood plasma	15	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M3_4	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M3_4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M3_4.raw	1	AC=MS:1002038;NT=label free	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-16	Homo sapiens	Blood plasma	16	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M4_1	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M4_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M4_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-16	Homo sapiens	Blood plasma	16	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M4_2	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M4_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M4_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-16	Homo sapiens	Blood plasma	16	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M4_3	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M4_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M4_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-16	Homo sapiens	Blood plasma	16	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M4_4	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M4_4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M4_4.raw	1	AC=MS:1002038;NT=label free	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-17	Homo sapiens	Blood plasma	17	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M5_1	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M5_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M5_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-17	Homo sapiens	Blood plasma	17	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M5_2	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M5_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M5_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-17	Homo sapiens	Blood plasma	17	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M5_3	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M5_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M5_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-17	Homo sapiens	Blood plasma	17	not applicable	not available	not available	male	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_M5_4	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_M5_4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_M5_4.raw	1	AC=MS:1002038;NT=label free	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-18	Homo sapiens	Blood plasma	18	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W1_1	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W1_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W1_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-18	Homo sapiens	Blood plasma	18	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W1_2	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W1_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W1_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-18	Homo sapiens	Blood plasma	18	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W1_3	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W1_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W1_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-18	Homo sapiens	Blood plasma	18	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W1_4	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W1_4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W1_4.raw	1	AC=MS:1002038;NT=label free	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-19	Homo sapiens	Blood plasma	19	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W2_1	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W2_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W2_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-19	Homo sapiens	Blood plasma	19	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W2_2	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W2_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W2_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-19	Homo sapiens	Blood plasma	19	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W2_3	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W2_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W2_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-19	Homo sapiens	Blood plasma	19	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W2_4	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W2_4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W2_4.raw	1	AC=MS:1002038;NT=label free	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-20	Homo sapiens	Blood plasma	20	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W3_1	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W3_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W3_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-20	Homo sapiens	Blood plasma	20	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W3_2	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W3_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W3_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-20	Homo sapiens	Blood plasma	20	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W3_3	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W3_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W3_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-20	Homo sapiens	Blood plasma	20	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W3_4	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W3_4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W3_4.raw	1	AC=MS:1002038;NT=label free	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-21	Homo sapiens	Blood plasma	21	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W4_1	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W4_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W4_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-21	Homo sapiens	Blood plasma	21	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W4_2	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W4_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W4_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-21	Homo sapiens	Blood plasma	21	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W4_3	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W4_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W4_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-21	Homo sapiens	Blood plasma	21	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W4_4	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W4_4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W4_4.raw	1	AC=MS:1002038;NT=label free	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-22	Homo sapiens	Blood plasma	22	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W5_1	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W5_1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W5_1.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-22	Homo sapiens	Blood plasma	22	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W5_2	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W5_2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W5_2.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-22	Homo sapiens	Blood plasma	22	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W5_3	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W5_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W5_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-22	Homo sapiens	Blood plasma	22	not applicable	not available	not available	female	not available	Healthy	depletion	1	no applicable	20141110_QEp1_LC7_PhGe_4_53_W5_4	proteomic profiling by mass spectrometry	20141110_QEp1_LC7_PhGe_4_53_W5_4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141110_QEp1_LC7_PhGe_4_53_W5_4.raw	1	AC=MS:1002038;NT=label free	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-23	Homo sapiens	Blood plasma	23	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_A1_141108192017	proteomic profiling by mass spectrometry	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_A1_141108192017.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141017_QEp1_LC7_PhGe_SA_4_45_Day2_A1_141108192017.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-23	Homo sapiens	Blood plasma	23	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_A4_141108195020	proteomic profiling by mass spectrometry	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_A4_141108195020.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141017_QEp1_LC7_PhGe_SA_4_45_Day2_A4_141108195020.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-23	Homo sapiens	Blood plasma	23	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_A7_141108202018	proteomic profiling by mass spectrometry	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_A7_141108202018.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141017_QEp1_LC7_PhGe_SA_4_45_Day2_A7_141108202018.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-23	Homo sapiens	Blood plasma	23	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_A10_141108205017	proteomic profiling by mass spectrometry	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_A10_141108205017.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141017_QEp1_LC7_PhGe_SA_4_45_Day2_A10_141108205017.raw	1	AC=MS:1002038;NT=label free	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-23	Homo sapiens	Blood plasma	23	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_A12_141108212016	proteomic profiling by mass spectrometry	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_A12_141108212016.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141017_QEp1_LC7_PhGe_SA_4_45_Day2_A12_141108212016.raw	1	AC=MS:1002038;NT=label free	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-23	Homo sapiens	Blood plasma	23	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_d1_141108134754	proteomic profiling by mass spectrometry	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_d1_141108134754.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141017_QEp1_LC7_PhGe_SA_4_45_Day2_d1_141108134754.raw	1	AC=MS:1002038;NT=label free	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-23	Homo sapiens	Blood plasma	23	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_d4_141108141755	proteomic profiling by mass spectrometry	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_d4_141108141755.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141017_QEp1_LC7_PhGe_SA_4_45_Day2_d4_141108141755.raw	1	AC=MS:1002038;NT=label free	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-23	Homo sapiens	Blood plasma	23	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_d7_141108144754	proteomic profiling by mass spectrometry	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_d7_141108144754.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141017_QEp1_LC7_PhGe_SA_4_45_Day2_d7_141108144754.raw	1	AC=MS:1002038;NT=label free	8	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-23	Homo sapiens	Blood plasma	23	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_d10_141108151752	proteomic profiling by mass spectrometry	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_d10_141108151752.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141017_QEp1_LC7_PhGe_SA_4_45_Day2_d10_141108151752.raw	1	AC=MS:1002038;NT=label free	9	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-23	Homo sapiens	Blood plasma	23	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_d12_141108154751	proteomic profiling by mass spectrometry	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_d12_141108154751.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141017_QEp1_LC7_PhGe_SA_4_45_Day2_d12_141108154751.raw	1	AC=MS:1002038;NT=label free	10	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-23	Homo sapiens	Blood plasma	23	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_h1_141107202236	proteomic profiling by mass spectrometry	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_h1_141107202236.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141017_QEp1_LC7_PhGe_SA_4_45_Day2_h1_141107202236.raw	1	AC=MS:1002038;NT=label free	11	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-23	Homo sapiens	Blood plasma	23	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_h4_141107205223	proteomic profiling by mass spectrometry	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_h4_141107205223.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141017_QEp1_LC7_PhGe_SA_4_45_Day2_h4_141107205223.raw	1	AC=MS:1002038;NT=label free	12	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-23	Homo sapiens	Blood plasma	23	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_h7_141107212216	proteomic profiling by mass spectrometry	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_h7_141107212216.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141017_QEp1_LC7_PhGe_SA_4_45_Day2_h7_141107212216.raw	1	AC=MS:1002038;NT=label free	13	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-23	Homo sapiens	Blood plasma	23	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_h10_141107215159	proteomic profiling by mass spectrometry	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_h10_141107215159.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141017_QEp1_LC7_PhGe_SA_4_45_Day2_h10_141107215159.raw	1	AC=MS:1002038;NT=label free	14	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-23	Homo sapiens	Blood plasma	23	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_h12_141107222137	proteomic profiling by mass spectrometry	20141017_QEp1_LC7_PhGe_SA_4_45_Day2_h12_141107222137.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141017_QEp1_LC7_PhGe_SA_4_45_Day2_h12_141107222137.raw	1	AC=MS:1002038;NT=label free	15	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-24	Homo sapiens	Blood plasma	24	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_1_141201130312	proteomic profiling by mass spectrometry	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_1_141201130312.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141201_qEp2_LC11_PhGe_SA_Day3SameSample_1_141201130312.raw	1	AC=MS:1002038;NT=label free	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-24	Homo sapiens	Blood plasma	24	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_2_141201133355	proteomic profiling by mass spectrometry	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_2_141201133355.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141201_qEp2_LC11_PhGe_SA_Day3SameSample_2_141201133355.raw	1	AC=MS:1002038;NT=label free	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-24	Homo sapiens	Blood plasma	24	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_3	proteomic profiling by mass spectrometry	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141201_qEp2_LC11_PhGe_SA_Day3SameSample_3.raw	1	AC=MS:1002038;NT=label free	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-24	Homo sapiens	Blood plasma	24	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_4	proteomic profiling by mass spectrometry	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141201_qEp2_LC11_PhGe_SA_Day3SameSample_4.raw	1	AC=MS:1002038;NT=label free	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-24	Homo sapiens	Blood plasma	24	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_5	proteomic profiling by mass spectrometry	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141201_qEp2_LC11_PhGe_SA_Day3SameSample_5.raw	1	AC=MS:1002038;NT=label free	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-24	Homo sapiens	Blood plasma	24	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_6	proteomic profiling by mass spectrometry	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141201_qEp2_LC11_PhGe_SA_Day3SameSample_6.raw	1	AC=MS:1002038;NT=label free	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-24	Homo sapiens	Blood plasma	24	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_7	proteomic profiling by mass spectrometry	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141201_qEp2_LC11_PhGe_SA_Day3SameSample_7.raw	1	AC=MS:1002038;NT=label free	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-24	Homo sapiens	Blood plasma	24	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_8	proteomic profiling by mass spectrometry	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141201_qEp2_LC11_PhGe_SA_Day3SameSample_8.raw	1	AC=MS:1002038;NT=label free	8	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-24	Homo sapiens	Blood plasma	24	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_9	proteomic profiling by mass spectrometry	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141201_qEp2_LC11_PhGe_SA_Day3SameSample_9.raw	1	AC=MS:1002038;NT=label free	9	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-24	Homo sapiens	Blood plasma	24	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_10	proteomic profiling by mass spectrometry	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141201_qEp2_LC11_PhGe_SA_Day3SameSample_10.raw	1	AC=MS:1002038;NT=label free	10	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-24	Homo sapiens	Blood plasma	24	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_11	proteomic profiling by mass spectrometry	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141201_qEp2_LC11_PhGe_SA_Day3SameSample_11.raw	1	AC=MS:1002038;NT=label free	11	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-24	Homo sapiens	Blood plasma	24	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_12	proteomic profiling by mass spectrometry	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141201_qEp2_LC11_PhGe_SA_Day3SameSample_12.raw	1	AC=MS:1002038;NT=label free	12	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-24	Homo sapiens	Blood plasma	24	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_13	proteomic profiling by mass spectrometry	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_13.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141201_qEp2_LC11_PhGe_SA_Day3SameSample_13.raw	1	AC=MS:1002038;NT=label free	13	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-24	Homo sapiens	Blood plasma	24	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_14	proteomic profiling by mass spectrometry	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_14.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141201_qEp2_LC11_PhGe_SA_Day3SameSample_14.raw	1	AC=MS:1002038;NT=label free	14	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
PXD002854-Sample-Plasma-24	Homo sapiens	Blood plasma	24	not applicable	not available	not available	not available	not available	Healthy	depletion	1	no applicable	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_15	proteomic profiling by mass spectrometry	20141201_qEp2_LC11_PhGe_SA_Day3SameSample_15.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD002854/20141201_qEp2_LC11_PhGe_SA_Day3SameSample_15.raw	1	AC=MS:1002038;NT=label free	15	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	7 ppm	20 ppm	Blood plasma
